Voyageur Pharmaceuticals (CVE:VM) Shares Up 9.1% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM) shares traded up 9.1% on Friday . The company traded as high as C$0.12 and last traded at C$0.12. 835,000 shares traded hands during mid-day trading, an increase of 756% from the average session volume of 97,601 shares. The stock had previously closed at C$0.11.

Voyageur Pharmaceuticals Stock Up 18.2%

The company has a debt-to-equity ratio of 6.05, a quick ratio of 0.84 and a current ratio of 0.18. The stock’s 50 day moving average price is C$0.10 and its 200-day moving average price is C$0.13. The company has a market cap of C$23.33 million, a PE ratio of -13.00 and a beta of 0.78.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.